U.S. Markets open in 7 hrs 39 mins

Redpoint Bio Corporation (RPBC)


Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.00160.00 (0.00%)
At close: 2:40PM EDT
People also watch
IRBSQTXBPRTXVIAPMYMX

Redpoint Bio Corporation

Albert Einstein Healthcare Network
5501 Old York Road
Philadelphia, PA 19141
United States
215-456-2312
http://www.redpointbio.com

SectorServices
IndustryResearch Services
Full Time Employees

Key Executives

NameTitlePayExercisedAge
Dr. R. Kyle Palmer Ph.D.Sr. Director of Discovery ResearchN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Redpoint Bio Corporation, a development stage biotechnology company, focuses on the development of healthier foods and new approaches for the treatment of diabetes and obesity by understanding the biology of taste and its relationship to metabolism, satiety, and diabetes. It enters into a license and commercialization agreement with International Flavors and Fragrances Inc. for the development, manufacture, use, and commercialization of RP44, which is a component of the stevia plant that works as a sweetness enhancer amplifying the existing sugary sweetness in a food or beverage. The company is based in Philadelphia, Pennsylvania.

Corporate Governance

Redpoint Bio Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.